Tirzepatide as a Dual Incretin Agonist: A Research Review | RemedyX Labs Research Library

A research summary of Tirzepatide, a Dual GIP/GLP-1 Receptor Co-Agonist for the Treatment of Type 2 Diabetes, examining tirzepatide as a dual incretin agonist: a research review. Cited source and RUO context from RemedyX Labs.